Characterization of Marburg virus glycoprotein in viral entry

Virology

Volumn 358, Issue 1, 2007, Pages 79-88

  Manicassamy, Balaji ^a   Wang, Jizhen ^a   Rumschlag, Emily ^a   Tymen, Stéphanie ^a   Volchkova, Valentina ^b   Volchkov, Viktor ^b   Rong, Lijun ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

Ebola virus GP; Filovirus glycoprotein; Marburg virus GP; Receptor binding domain; Receptor interference; Viral entry

Indexed keywords

MUCIN; PROTEIN MGP[289-501]; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; EBOLA VIRUS; FILOVIRIDAE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PSEUDOTYPING; RECEPTOR BINDING; VIRUS HEMORRHAGIC FEVER; VIRUS TRANSMISSION; VIRUS TYPING;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; CELL LINE; HIV; HUMANS; MARBURGVIRUS; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, VIRUS; SEQUENCE HOMOLOGY, AMINO ACID; VIRAL ENVELOPE PROTEINS; VIRAL INTERFERENCE; VIRUS ASSEMBLY; VIRUS INTERNALIZATION;

EBOLA VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; LAKE VICTORIA MARBURGVIRUS; MARBURGVIRUS;

EID: 33846086605     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.06.041     Document Type: Article

References (44)

1. Alazard-Dany N., Volchkova V., Reynard O., Carbonnelle C., Dolnik O., Ottmann M., Khromykh A., and Volchkov V.E. Ebola virus glycoprotein GP is not cytotoxic when expressed constitutively at a moderate level. J. Gen. Virol. 87 Pt. 5 (2006) 1247-1257
2. Alvarez C.P., Lasala F., Carrillo J., Muniz O., Corbi A.L., and Delgado R. C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans. J. Virol. 76 13 (2002) 6841-6844
3. Becker S., Spiess M., and Klenk H.D. The asialoglycoprotein receptor is a potential liver-specific receptor for Marburg virus. J. Gen. Virol. 76 Pt. 2 (1995) 393-399
4. Bosio C.M., Moore B.D., Warfield K.L., Ruthel G., Mohamadzadeh M., Aman M.J., and Bavari S. Ebola and Marburg virus-like particles activate human myeloid dendritic cells. Virology 326 2 (2004) 280-287
5. Bray M., and Geisbert T.W. Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever. Int. J. Biochem. Cell. Biol. 37 8 (2005) 1560-1566
6. Chan S.Y., Empig C.J., Welte F.J., Speck R.F., Schmaljohn A., Kreisberg J.F., and Goldsmith M.A. Folate receptor-alpha is a cofactor for cellular entry by Marburg and Ebola viruses. Cell 106 1 (2001) 117-126
7. Chandran K., Sullivan N.J., Felbor U., Whelan S.P., and Cunningham J.M. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 308 5728 (2005) 1643-1645
8. Connor R.I., Chen B.K., Choe S., and Landau N.R. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 206 2 (1995) 935-944
9. Dolnik O., Volchkova V., Garten W., Carbonnelle C., Becker S., Kahnt J., Stroher U., Klenk H.D., and Volchkov V. Ectodomain shedding of the glycoprotein GP of Ebola virus. EMBO J. 23 10 (2004) 2175-2184
10. Feldmann H., Volchkov V.E., Volchkova V.A., Stroher U., and Klenk H.D. Biosynthesis and role of filoviral glycoproteins. J. Gen. Virol. 82 Pt. 12 (2001) 2839-2848
11. Feldmann H., Wahl-Jensen V., Jones S.M., and Stroher U. Ebola virus ecology: a continuing mystery. Trends Microbiol. 12 10 (2004) 433-437
12. He J., Choe S., Walker R., Di Marzio P., Morgan D.O., and Landau N.R. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J. Virol. 69 11 (1995) 6705-6711
13. Jeffers S.A., Sanders D.A., and Sanchez A. Covalent modifications of the ebola virus glycoprotein. J. Virol. 76 24 (2002) 12463-12472
14. Jones S.M., Feldmann H., Stroher U., Geisbert J.B., Fernando L., Grolla A., Klenk H.D., Sullivan N.J., Volchkov V.E., Fritz E.A., Daddario K.M., Hensley L.E., Jahrling P.B., and Geisbert T.W. Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nat. Med. 11 7 (2005) 786-790
15. Klucking S., Adkins H.B., and Young J.A. Resistance to infection by subgroups B, D, and E avian sarcoma and leukosis viruses is explained by a premature stop codon within a resistance allele of the tvb receptor gene. J. Virol. 76 15 (2002) 7918-7921
16. Kuhn J.H., Radoshitzky S.R., Guth A.C., Warfield K.L., Li W., Vincent M.J., Towner J.S., Nichol S.T., Bavari S., Choe H., Aman M.J., and Farzan M. Conserved receptor-binding domains of lake Victoria marburgvirus and zaire ebolavirus bind a common receptor. J. Biol. Chem. 281 23 (2006) 15951-15958
17. Leroy E.M., Kumulungui B., Pourrut X., Rouquet P., Hassanin A., Yaba P., Delicat A., Paweska J.T., Gonzalez J.P., and Swanepoel R. Fruit bats as reservoirs of Ebola virus. Nature 438 7068 (2005) 575-576
18. Lin G., Simmons G., Pohlmann S., Baribaud F., Ni H., Leslie G.J., Haggarty B.S., Bates P., Weissman D., Hoxie J.A., and Doms R.W. Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR. J. Virol. 77 2 (2003) 1337-1346
19. Manicassamy B., Wang J., Jiang H., and Rong L. Comprehensive analysis of ebola virus GP1 in viral entry. J. Virol. 79 8 (2005) 4793-4805
20. Martin R.A., and Nayak D.P. Receptor interference mediated by the envelope glycoproteins of various HIV-1 and HIV-2 isolates. Virus Res. 45 2 (1996) 135-145
21. Marzi A., Gramberg T., Simmons G., Moller P., Rennekamp A.J., Krumbiegel M., Geier M., Eisemann J., Turza N., Saunier B., Steinkasserer A., Becker S., Bates P., Hofmann H., and Pohlmann S. DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus. J. Virol. 78 21 (2004) 12090-12095
22. Naldini L., Blomer U., Gallay P., Ory D., Mulligan R., Gage F.H., Verma I.M., and Trono D. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272 5259 (1996) 263-267
23. Nethe M., Berkhout B., and van der Kuyl A.C. Retroviral superinfection resistance. Retrovirology 2 1 (2005) 52
24. Peterson A.T., Bauer J.T., and Mills J.N. Ecologic and geographic distribution of filovirus disease. Emerg. Infect Dis. 10 1 (2004) 40-47
25. Sanchez A., Kiley M.P., Holloway B.P., and Auperin D.D. Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus. Virus Res. 29 3 (1993) 215-240
26. Sanchez A., Trappier S.G., Mahy B.W., Peters C.J., and Nichol S.T. The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proc. Natl. Acad. Sci. U.S.A. 93 8 (1996) 3602-3607
27. Sanchez A., Trappier S.G., Stroher U., Nichol S.T., Bowen M.D., and Feldmann H. Variation in the glycoprotein and VP35 genes of Marburg virus strains. Virology 240 1 (1998) 138-146
28. Sanchez A., Khan A.S., Zaki S.R., Nabel G.J., Ksiazek T.G., and Peters C.G. Filoviridae: Marburg and Ebola viruses. In: Howley D.M.K.a.P.M. (Ed). Fields Virology. 4th ed. vol. 1 (2001), Lippincott Williams and Wilkins, Philadelphia, PA
29. Schornberg K., Matsuyama S., Kabsch K., Delos S., Bouton A., and White J. Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein. J. Virol. 80 8 (2006) 4174-4178
30. Simmons G., Wool-Lewis R.J., Baribaud F., Netter R.C., and Bates P. Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence. J. Virol. 76 5 (2002) 2518-2528
31. Simmons G., Reeves J.D., Grogan C.C., Vandenberghe L.H., Baribaud F., Whitbeck J.C., Burke E., Buchmeier M.J., Soilleux E.J., Riley J.L., Doms R.W., Bates P., and Pohlmann S. DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells. Virology 305 1 (2003) 115-123
32. Simmons G., Rennekamp A.J., Chai N., Vandenberghe L.H., Riley J.L., and Bates P. Folate receptor alpha and caveolae are not required for Ebola virus glycoprotein-mediated viral infection. J. Virol. 77 24 (2003) 13433-13438
33. Simon J.H., Fouchier R.A., Southerling T.E., Guerra C.B., Grant C.K., and Malim M.H. The Vif and Gag proteins of human immunodeficiency virus type 1 colocalize in infected human T cells. J. Virol. 71 7 (1997) 5259-5267
34. Stroher U., West E., Bugany H., Klenk H.D., Schnittler H.J., and Feldmann H. Infection and activation of monocytes by Marburg and Ebola viruses. J. Virol. 75 22 (2001) 11025-11033
35. Sullivan N.J., Sanchez A., Rollin P.E., Yang Z.Y., and Nabel G.J. Development of a preventive vaccine for Ebola virus infection in primates. Nature 408 6812 (2000) 605-609
36. Sullivan N.J., Geisbert T.W., Geisbert J.B., Xu L., Yang Z.Y., Roederer M., Koup R.A., Jahrling P.B., and Nabel G.J. Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates. Nature 424 6949 (2003) 681-684
37. Takada A., Watanabe S., Ito H., Okazaki K., Kida H., and Kawaoka Y. Downregulation of beta1 integrins by Ebola virus glycoprotein: implication for virus entry. Virology 278 1 (2000) 20-26
38. Takada A., Fujioka K., Tsuiji M., Morikawa A., Higashi N., Ebihara H., Kobasa D., Feldmann H., Irimura T., and Kawaoka Y. Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry. J. Virol. 78 6 (2004) 2943-2947
39. Volchkov V.E., Becker S., Volchkova V.A., Ternovoj V.A., Kotov A.N., Netesov S.V., and Klenk H.D. GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases. Virology 214 2 (1995) 421-430
40. Volchkov V.E., Feldmann H., Volchkova V.A., and Klenk H.D. Processing of the Ebola virus glycoprotein by the proprotein convertase furin. Proc. Natl. Acad. Sci. U.S.A. 95 10 (1998) 5762-5767
41. Volchkov V.E., Volchkova V.A., Stroher U., Becker S., Dolnik O., Cieplik M., Garten W., Klenk H.D., and Feldmann H. Proteolytic processing of Marburg virus glycoprotein. Virology 268 1 (2000) 1-6
42. Weiss R.A. Cellular receptors and viral glycoproteins involved in retrovirus entry. In: Levy J.A. (Ed). The Retroviridae vol. 2 (1993), Plenum Press, New York, NY
43. Xu L., Sanchez A., Yang Z., Zaki S.R., Nabel E.G., Nichol S.T., and Nabel G.J. Immunization for Ebola virus infection. Nat. Med. 4 1 (1998) 37-42
44. Yang Z.Y., Duckers H.J., Sullivan N.J., Sanchez A., Nabel E.G., and Nabel G.J. Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury. Nat. Med. 6 8 (2000) 886-889